Global Adeno-Associated Virus Vectors in Gene Therapy Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Adeno-associated viruses (AAV) are small viruses that infect humans and some other primate species. They belong to the genus Dependoparvovirus, which in turn belongs to the family Parvoviridae. They are small (20 nm) replication-defective, nonenveloped viruses and have linear single-stranded DNA (ssDNA) genome of approximately 4.8 kilobases (kb).
According to our (Global Info Research) latest study, the global Adeno-Associated Virus Vectors in Gene Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Adeno-Associated Virus Vectors in Gene Therapy market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Adeno-Associated Virus Vectors in Gene Therapy market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Adeno-Associated Virus Vectors in Gene Therapy market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Adeno-Associated Virus Vectors in Gene Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Adeno-Associated Virus Vectors in Gene Therapy market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Adeno-Associated Virus Vectors in Gene Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Adeno-Associated Virus Vectors in Gene Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amicus Therapeutics, Asklepios Biopharmaceutical, BioMarin Pharmaceutical, Coave Therapeutics and MeiraGTx, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Adeno-Associated Virus Vectors in Gene Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Adeno-Associated Virus Vectors in Gene Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Adeno-Associated Virus Vectors in Gene Therapy, with price, sales, revenue and global market share of Adeno-Associated Virus Vectors in Gene Therapy from 2018 to 2023.
Chapter 3, the Adeno-Associated Virus Vectors in Gene Therapy competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Adeno-Associated Virus Vectors in Gene Therapy breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Adeno-Associated Virus Vectors in Gene Therapy market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Adeno-Associated Virus Vectors in Gene Therapy.
Chapter 14 and 15, to describe Adeno-Associated Virus Vectors in Gene Therapy sales channel, distributors, customers, research findings and conclusion.
According to our (Global Info Research) latest study, the global Adeno-Associated Virus Vectors in Gene Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Adeno-Associated Virus Vectors in Gene Therapy market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Adeno-Associated Virus Vectors in Gene Therapy market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Adeno-Associated Virus Vectors in Gene Therapy market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Adeno-Associated Virus Vectors in Gene Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Adeno-Associated Virus Vectors in Gene Therapy market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Adeno-Associated Virus Vectors in Gene Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Adeno-Associated Virus Vectors in Gene Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amicus Therapeutics, Asklepios Biopharmaceutical, BioMarin Pharmaceutical, Coave Therapeutics and MeiraGTx, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Adeno-Associated Virus Vectors in Gene Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Serotype 2 (AVV 2)
- Synthetic Serotypes
- Others
- Alzheimer's Disease
- Cystic Dibrosis
- Hemophilia B
- Parkinson's Disease
- Amicus Therapeutics
- Asklepios Biopharmaceutical
- BioMarin Pharmaceutical
- Coave Therapeutics
- MeiraGTx
- Neurocrine Biosciences
- Pfizer
- Roche Holding
- Sangamo Therapeutics
- Sarepta Therapeutics
- Spark Therapeutics
- Voyager Therapeutics
- NightstaRx
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Adeno-Associated Virus Vectors in Gene Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Adeno-Associated Virus Vectors in Gene Therapy, with price, sales, revenue and global market share of Adeno-Associated Virus Vectors in Gene Therapy from 2018 to 2023.
Chapter 3, the Adeno-Associated Virus Vectors in Gene Therapy competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Adeno-Associated Virus Vectors in Gene Therapy breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Adeno-Associated Virus Vectors in Gene Therapy market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Adeno-Associated Virus Vectors in Gene Therapy.
Chapter 14 and 15, to describe Adeno-Associated Virus Vectors in Gene Therapy sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Adeno-Associated Virus Vectors in Gene Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Serotype 2 (AVV 2)
1.3.3 Synthetic Serotypes
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Alzheimer's Disease
1.4.3 Cystic Dibrosis
1.4.4 Hemophilia B
1.4.5 Parkinson's Disease
1.5 Global Adeno-Associated Virus Vectors in Gene Therapy Market Size & Forecast
1.5.1 Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (2018-2029)
1.5.3 Global Adeno-Associated Virus Vectors in Gene Therapy Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Amicus Therapeutics
2.1.1 Amicus Therapeutics Details
2.1.2 Amicus Therapeutics Major Business
2.1.3 Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.1.4 Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Amicus Therapeutics Recent Developments/Updates
2.2 Asklepios Biopharmaceutical
2.2.1 Asklepios Biopharmaceutical Details
2.2.2 Asklepios Biopharmaceutical Major Business
2.2.3 Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.2.4 Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Asklepios Biopharmaceutical Recent Developments/Updates
2.3 BioMarin Pharmaceutical
2.3.1 BioMarin Pharmaceutical Details
2.3.2 BioMarin Pharmaceutical Major Business
2.3.3 BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.3.4 BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 BioMarin Pharmaceutical Recent Developments/Updates
2.4 Coave Therapeutics
2.4.1 Coave Therapeutics Details
2.4.2 Coave Therapeutics Major Business
2.4.3 Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.4.4 Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Coave Therapeutics Recent Developments/Updates
2.5 MeiraGTx
2.5.1 MeiraGTx Details
2.5.2 MeiraGTx Major Business
2.5.3 MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.5.4 MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 MeiraGTx Recent Developments/Updates
2.6 Neurocrine Biosciences
2.6.1 Neurocrine Biosciences Details
2.6.2 Neurocrine Biosciences Major Business
2.6.3 Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.6.4 Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Neurocrine Biosciences Recent Developments/Updates
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.7.4 Pfizer Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Pfizer Recent Developments/Updates
2.8 Roche Holding
2.8.1 Roche Holding Details
2.8.2 Roche Holding Major Business
2.8.3 Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.8.4 Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Roche Holding Recent Developments/Updates
2.9 Sangamo Therapeutics
2.9.1 Sangamo Therapeutics Details
2.9.2 Sangamo Therapeutics Major Business
2.9.3 Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.9.4 Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sangamo Therapeutics Recent Developments/Updates
2.10 Sarepta Therapeutics
2.10.1 Sarepta Therapeutics Details
2.10.2 Sarepta Therapeutics Major Business
2.10.3 Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.10.4 Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Sarepta Therapeutics Recent Developments/Updates
2.11 Spark Therapeutics
2.11.1 Spark Therapeutics Details
2.11.2 Spark Therapeutics Major Business
2.11.3 Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.11.4 Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Spark Therapeutics Recent Developments/Updates
2.12 Voyager Therapeutics
2.12.1 Voyager Therapeutics Details
2.12.2 Voyager Therapeutics Major Business
2.12.3 Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.12.4 Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Voyager Therapeutics Recent Developments/Updates
2.13 NightstaRx
2.13.1 NightstaRx Details
2.13.2 NightstaRx Major Business
2.13.3 NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.13.4 NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 NightstaRx Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ADENO-ASSOCIATED VIRUS VECTORS IN GENE THERAPY BY MANUFACTURER
3.1 Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Manufacturer (2018-2023)
3.2 Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Manufacturer (2018-2023)
3.3 Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Adeno-Associated Virus Vectors in Gene Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Adeno-Associated Virus Vectors in Gene Therapy Manufacturer Market Share in 2022
3.4.2 Top 6 Adeno-Associated Virus Vectors in Gene Therapy Manufacturer Market Share in 2022
3.5 Adeno-Associated Virus Vectors in Gene Therapy Market: Overall Company Footprint Analysis
3.5.1 Adeno-Associated Virus Vectors in Gene Therapy Market: Region Footprint
3.5.2 Adeno-Associated Virus Vectors in Gene Therapy Market: Company Product Type Footprint
3.5.3 Adeno-Associated Virus Vectors in Gene Therapy Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Adeno-Associated Virus Vectors in Gene Therapy Market Size by Region
4.1.1 Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Region (2018-2029)
4.1.2 Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Region (2018-2029)
4.1.3 Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Region (2018-2029)
4.2 North America Adeno-Associated Virus Vectors in Gene Therapy Consumption Value (2018-2029)
4.3 Europe Adeno-Associated Virus Vectors in Gene Therapy Consumption Value (2018-2029)
4.4 Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Consumption Value (2018-2029)
4.5 South America Adeno-Associated Virus Vectors in Gene Therapy Consumption Value (2018-2029)
4.6 Middle East and Africa Adeno-Associated Virus Vectors in Gene Therapy Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2018-2029)
5.2 Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Type (2018-2029)
5.3 Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2018-2029)
6.2 Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Application (2018-2029)
6.3 Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2018-2029)
7.2 North America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2018-2029)
7.3 North America Adeno-Associated Virus Vectors in Gene Therapy Market Size by Country
7.3.1 North America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Country (2018-2029)
7.3.2 North America Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2018-2029)
8.2 Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2018-2029)
8.3 Europe Adeno-Associated Virus Vectors in Gene Therapy Market Size by Country
8.3.1 Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Country (2018-2029)
8.3.2 Europe Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Market Size by Region
9.3.1 Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2018-2029)
10.2 South America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2018-2029)
10.3 South America Adeno-Associated Virus Vectors in Gene Therapy Market Size by Country
10.3.1 South America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Country (2018-2029)
10.3.2 South America Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Market Size by Country
11.3.1 Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Adeno-Associated Virus Vectors in Gene Therapy Market Drivers
12.2 Adeno-Associated Virus Vectors in Gene Therapy Market Restraints
12.3 Adeno-Associated Virus Vectors in Gene Therapy Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Adeno-Associated Virus Vectors in Gene Therapy and Key Manufacturers
13.2 Manufacturing Costs Percentage of Adeno-Associated Virus Vectors in Gene Therapy
13.3 Adeno-Associated Virus Vectors in Gene Therapy Production Process
13.4 Adeno-Associated Virus Vectors in Gene Therapy Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Adeno-Associated Virus Vectors in Gene Therapy Typical Distributors
14.3 Adeno-Associated Virus Vectors in Gene Therapy Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Adeno-Associated Virus Vectors in Gene Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Serotype 2 (AVV 2)
1.3.3 Synthetic Serotypes
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Alzheimer's Disease
1.4.3 Cystic Dibrosis
1.4.4 Hemophilia B
1.4.5 Parkinson's Disease
1.5 Global Adeno-Associated Virus Vectors in Gene Therapy Market Size & Forecast
1.5.1 Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (2018-2029)
1.5.3 Global Adeno-Associated Virus Vectors in Gene Therapy Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Amicus Therapeutics
2.1.1 Amicus Therapeutics Details
2.1.2 Amicus Therapeutics Major Business
2.1.3 Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.1.4 Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Amicus Therapeutics Recent Developments/Updates
2.2 Asklepios Biopharmaceutical
2.2.1 Asklepios Biopharmaceutical Details
2.2.2 Asklepios Biopharmaceutical Major Business
2.2.3 Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.2.4 Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Asklepios Biopharmaceutical Recent Developments/Updates
2.3 BioMarin Pharmaceutical
2.3.1 BioMarin Pharmaceutical Details
2.3.2 BioMarin Pharmaceutical Major Business
2.3.3 BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.3.4 BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 BioMarin Pharmaceutical Recent Developments/Updates
2.4 Coave Therapeutics
2.4.1 Coave Therapeutics Details
2.4.2 Coave Therapeutics Major Business
2.4.3 Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.4.4 Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Coave Therapeutics Recent Developments/Updates
2.5 MeiraGTx
2.5.1 MeiraGTx Details
2.5.2 MeiraGTx Major Business
2.5.3 MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.5.4 MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 MeiraGTx Recent Developments/Updates
2.6 Neurocrine Biosciences
2.6.1 Neurocrine Biosciences Details
2.6.2 Neurocrine Biosciences Major Business
2.6.3 Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.6.4 Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Neurocrine Biosciences Recent Developments/Updates
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.7.4 Pfizer Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Pfizer Recent Developments/Updates
2.8 Roche Holding
2.8.1 Roche Holding Details
2.8.2 Roche Holding Major Business
2.8.3 Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.8.4 Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Roche Holding Recent Developments/Updates
2.9 Sangamo Therapeutics
2.9.1 Sangamo Therapeutics Details
2.9.2 Sangamo Therapeutics Major Business
2.9.3 Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.9.4 Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sangamo Therapeutics Recent Developments/Updates
2.10 Sarepta Therapeutics
2.10.1 Sarepta Therapeutics Details
2.10.2 Sarepta Therapeutics Major Business
2.10.3 Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.10.4 Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Sarepta Therapeutics Recent Developments/Updates
2.11 Spark Therapeutics
2.11.1 Spark Therapeutics Details
2.11.2 Spark Therapeutics Major Business
2.11.3 Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.11.4 Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Spark Therapeutics Recent Developments/Updates
2.12 Voyager Therapeutics
2.12.1 Voyager Therapeutics Details
2.12.2 Voyager Therapeutics Major Business
2.12.3 Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.12.4 Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Voyager Therapeutics Recent Developments/Updates
2.13 NightstaRx
2.13.1 NightstaRx Details
2.13.2 NightstaRx Major Business
2.13.3 NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Product and Services
2.13.4 NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 NightstaRx Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ADENO-ASSOCIATED VIRUS VECTORS IN GENE THERAPY BY MANUFACTURER
3.1 Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Manufacturer (2018-2023)
3.2 Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Manufacturer (2018-2023)
3.3 Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Adeno-Associated Virus Vectors in Gene Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Adeno-Associated Virus Vectors in Gene Therapy Manufacturer Market Share in 2022
3.4.2 Top 6 Adeno-Associated Virus Vectors in Gene Therapy Manufacturer Market Share in 2022
3.5 Adeno-Associated Virus Vectors in Gene Therapy Market: Overall Company Footprint Analysis
3.5.1 Adeno-Associated Virus Vectors in Gene Therapy Market: Region Footprint
3.5.2 Adeno-Associated Virus Vectors in Gene Therapy Market: Company Product Type Footprint
3.5.3 Adeno-Associated Virus Vectors in Gene Therapy Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Adeno-Associated Virus Vectors in Gene Therapy Market Size by Region
4.1.1 Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Region (2018-2029)
4.1.2 Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Region (2018-2029)
4.1.3 Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Region (2018-2029)
4.2 North America Adeno-Associated Virus Vectors in Gene Therapy Consumption Value (2018-2029)
4.3 Europe Adeno-Associated Virus Vectors in Gene Therapy Consumption Value (2018-2029)
4.4 Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Consumption Value (2018-2029)
4.5 South America Adeno-Associated Virus Vectors in Gene Therapy Consumption Value (2018-2029)
4.6 Middle East and Africa Adeno-Associated Virus Vectors in Gene Therapy Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2018-2029)
5.2 Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Type (2018-2029)
5.3 Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2018-2029)
6.2 Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Application (2018-2029)
6.3 Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2018-2029)
7.2 North America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2018-2029)
7.3 North America Adeno-Associated Virus Vectors in Gene Therapy Market Size by Country
7.3.1 North America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Country (2018-2029)
7.3.2 North America Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2018-2029)
8.2 Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2018-2029)
8.3 Europe Adeno-Associated Virus Vectors in Gene Therapy Market Size by Country
8.3.1 Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Country (2018-2029)
8.3.2 Europe Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Market Size by Region
9.3.1 Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2018-2029)
10.2 South America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2018-2029)
10.3 South America Adeno-Associated Virus Vectors in Gene Therapy Market Size by Country
10.3.1 South America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Country (2018-2029)
10.3.2 South America Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Market Size by Country
11.3.1 Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Adeno-Associated Virus Vectors in Gene Therapy Market Drivers
12.2 Adeno-Associated Virus Vectors in Gene Therapy Market Restraints
12.3 Adeno-Associated Virus Vectors in Gene Therapy Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Adeno-Associated Virus Vectors in Gene Therapy and Key Manufacturers
13.2 Manufacturing Costs Percentage of Adeno-Associated Virus Vectors in Gene Therapy
13.3 Adeno-Associated Virus Vectors in Gene Therapy Production Process
13.4 Adeno-Associated Virus Vectors in Gene Therapy Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Adeno-Associated Virus Vectors in Gene Therapy Typical Distributors
14.3 Adeno-Associated Virus Vectors in Gene Therapy Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Amicus Therapeutics Basic Information, Manufacturing Base and Competitors
Table 4. Amicus Therapeutics Major Business
Table 5. Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 6. Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Amicus Therapeutics Recent Developments/Updates
Table 8. Asklepios Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 9. Asklepios Biopharmaceutical Major Business
Table 10. Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 11. Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Asklepios Biopharmaceutical Recent Developments/Updates
Table 13. BioMarin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 14. BioMarin Pharmaceutical Major Business
Table 15. BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 16. BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. BioMarin Pharmaceutical Recent Developments/Updates
Table 18. Coave Therapeutics Basic Information, Manufacturing Base and Competitors
Table 19. Coave Therapeutics Major Business
Table 20. Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 21. Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Coave Therapeutics Recent Developments/Updates
Table 23. MeiraGTx Basic Information, Manufacturing Base and Competitors
Table 24. MeiraGTx Major Business
Table 25. MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 26. MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. MeiraGTx Recent Developments/Updates
Table 28. Neurocrine Biosciences Basic Information, Manufacturing Base and Competitors
Table 29. Neurocrine Biosciences Major Business
Table 30. Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 31. Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Neurocrine Biosciences Recent Developments/Updates
Table 33. Pfizer Basic Information, Manufacturing Base and Competitors
Table 34. Pfizer Major Business
Table 35. Pfizer Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 36. Pfizer Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Pfizer Recent Developments/Updates
Table 38. Roche Holding Basic Information, Manufacturing Base and Competitors
Table 39. Roche Holding Major Business
Table 40. Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 41. Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Roche Holding Recent Developments/Updates
Table 43. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 44. Sangamo Therapeutics Major Business
Table 45. Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 46. Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Sangamo Therapeutics Recent Developments/Updates
Table 48. Sarepta Therapeutics Basic Information, Manufacturing Base and Competitors
Table 49. Sarepta Therapeutics Major Business
Table 50. Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 51. Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Sarepta Therapeutics Recent Developments/Updates
Table 53. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table 54. Spark Therapeutics Major Business
Table 55. Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 56. Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Spark Therapeutics Recent Developments/Updates
Table 58. Voyager Therapeutics Basic Information, Manufacturing Base and Competitors
Table 59. Voyager Therapeutics Major Business
Table 60. Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 61. Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Voyager Therapeutics Recent Developments/Updates
Table 63. NightstaRx Basic Information, Manufacturing Base and Competitors
Table 64. NightstaRx Major Business
Table 65. NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 66. NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. NightstaRx Recent Developments/Updates
Table 68. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Manufacturer (2018-2023) & (Kg)
Table 69. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Manufacturer (2018-2023) & (US$/Kg)
Table 71. Market Position of Manufacturers in Adeno-Associated Virus Vectors in Gene Therapy, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and Adeno-Associated Virus Vectors in Gene Therapy Production Site of Key Manufacturer
Table 73. Adeno-Associated Virus Vectors in Gene Therapy Market: Company Product Type Footprint
Table 74. Adeno-Associated Virus Vectors in Gene Therapy Market: Company Product Application Footprint
Table 75. Adeno-Associated Virus Vectors in Gene Therapy New Market Entrants and Barriers to Market Entry
Table 76. Adeno-Associated Virus Vectors in Gene Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Region (2018-2023) & (Kg)
Table 78. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Region (2024-2029) & (Kg)
Table 79. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Region (2018-2023) & (US$/Kg)
Table 82. Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Region (2024-2029) & (US$/Kg)
Table 83. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2018-2023) & (Kg)
Table 84. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2024-2029) & (Kg)
Table 85. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Type (2018-2023) & (US$/Kg)
Table 88. Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Type (2024-2029) & (US$/Kg)
Table 89. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2018-2023) & (Kg)
Table 90. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2024-2029) & (Kg)
Table 91. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Application (2018-2023) & (US$/Kg)
Table 94. Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Application (2024-2029) & (US$/Kg)
Table 95. North America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2018-2023) & (Kg)
Table 96. North America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2024-2029) & (Kg)
Table 97. North America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2018-2023) & (Kg)
Table 98. North America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2024-2029) & (Kg)
Table 99. North America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Country (2018-2023) & (Kg)
Table 100. North America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Country (2024-2029) & (Kg)
Table 101. North America Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2018-2023) & (Kg)
Table 104. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2024-2029) & (Kg)
Table 105. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2018-2023) & (Kg)
Table 106. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2024-2029) & (Kg)
Table 107. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Country (2018-2023) & (Kg)
Table 108. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Country (2024-2029) & (Kg)
Table 109. Europe Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2018-2023) & (Kg)
Table 112. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2024-2029) & (Kg)
Table 113. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2018-2023) & (Kg)
Table 114. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2024-2029) & (Kg)
Table 115. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Region (2018-2023) & (Kg)
Table 116. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Region (2024-2029) & (Kg)
Table 117. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2018-2023) & (Kg)
Table 120. South America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2024-2029) & (Kg)
Table 121. South America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2018-2023) & (Kg)
Table 122. South America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2024-2029) & (Kg)
Table 123. South America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Country (2018-2023) & (Kg)
Table 124. South America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Country (2024-2029) & (Kg)
Table 125. South America Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2018-2023) & (Kg)
Table 128. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2024-2029) & (Kg)
Table 129. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2018-2023) & (Kg)
Table 130. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2024-2029) & (Kg)
Table 131. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Region (2018-2023) & (Kg)
Table 132. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Region (2024-2029) & (Kg)
Table 133. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 135. Adeno-Associated Virus Vectors in Gene Therapy Raw Material
Table 136. Key Manufacturers of Adeno-Associated Virus Vectors in Gene Therapy Raw Materials
Table 137. Adeno-Associated Virus Vectors in Gene Therapy Typical Distributors
Table 138. Adeno-Associated Virus Vectors in Gene Therapy Typical Customers
Table 1. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Amicus Therapeutics Basic Information, Manufacturing Base and Competitors
Table 4. Amicus Therapeutics Major Business
Table 5. Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 6. Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Amicus Therapeutics Recent Developments/Updates
Table 8. Asklepios Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 9. Asklepios Biopharmaceutical Major Business
Table 10. Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 11. Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Asklepios Biopharmaceutical Recent Developments/Updates
Table 13. BioMarin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 14. BioMarin Pharmaceutical Major Business
Table 15. BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 16. BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. BioMarin Pharmaceutical Recent Developments/Updates
Table 18. Coave Therapeutics Basic Information, Manufacturing Base and Competitors
Table 19. Coave Therapeutics Major Business
Table 20. Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 21. Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Coave Therapeutics Recent Developments/Updates
Table 23. MeiraGTx Basic Information, Manufacturing Base and Competitors
Table 24. MeiraGTx Major Business
Table 25. MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 26. MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. MeiraGTx Recent Developments/Updates
Table 28. Neurocrine Biosciences Basic Information, Manufacturing Base and Competitors
Table 29. Neurocrine Biosciences Major Business
Table 30. Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 31. Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Neurocrine Biosciences Recent Developments/Updates
Table 33. Pfizer Basic Information, Manufacturing Base and Competitors
Table 34. Pfizer Major Business
Table 35. Pfizer Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 36. Pfizer Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Pfizer Recent Developments/Updates
Table 38. Roche Holding Basic Information, Manufacturing Base and Competitors
Table 39. Roche Holding Major Business
Table 40. Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 41. Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Roche Holding Recent Developments/Updates
Table 43. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 44. Sangamo Therapeutics Major Business
Table 45. Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 46. Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Sangamo Therapeutics Recent Developments/Updates
Table 48. Sarepta Therapeutics Basic Information, Manufacturing Base and Competitors
Table 49. Sarepta Therapeutics Major Business
Table 50. Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 51. Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Sarepta Therapeutics Recent Developments/Updates
Table 53. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table 54. Spark Therapeutics Major Business
Table 55. Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 56. Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Spark Therapeutics Recent Developments/Updates
Table 58. Voyager Therapeutics Basic Information, Manufacturing Base and Competitors
Table 59. Voyager Therapeutics Major Business
Table 60. Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 61. Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Voyager Therapeutics Recent Developments/Updates
Table 63. NightstaRx Basic Information, Manufacturing Base and Competitors
Table 64. NightstaRx Major Business
Table 65. NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 66. NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. NightstaRx Recent Developments/Updates
Table 68. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Manufacturer (2018-2023) & (Kg)
Table 69. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Manufacturer (2018-2023) & (US$/Kg)
Table 71. Market Position of Manufacturers in Adeno-Associated Virus Vectors in Gene Therapy, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and Adeno-Associated Virus Vectors in Gene Therapy Production Site of Key Manufacturer
Table 73. Adeno-Associated Virus Vectors in Gene Therapy Market: Company Product Type Footprint
Table 74. Adeno-Associated Virus Vectors in Gene Therapy Market: Company Product Application Footprint
Table 75. Adeno-Associated Virus Vectors in Gene Therapy New Market Entrants and Barriers to Market Entry
Table 76. Adeno-Associated Virus Vectors in Gene Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Region (2018-2023) & (Kg)
Table 78. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Region (2024-2029) & (Kg)
Table 79. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Region (2018-2023) & (US$/Kg)
Table 82. Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Region (2024-2029) & (US$/Kg)
Table 83. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2018-2023) & (Kg)
Table 84. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2024-2029) & (Kg)
Table 85. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Type (2018-2023) & (US$/Kg)
Table 88. Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Type (2024-2029) & (US$/Kg)
Table 89. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2018-2023) & (Kg)
Table 90. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2024-2029) & (Kg)
Table 91. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Application (2018-2023) & (US$/Kg)
Table 94. Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Application (2024-2029) & (US$/Kg)
Table 95. North America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2018-2023) & (Kg)
Table 96. North America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2024-2029) & (Kg)
Table 97. North America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2018-2023) & (Kg)
Table 98. North America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2024-2029) & (Kg)
Table 99. North America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Country (2018-2023) & (Kg)
Table 100. North America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Country (2024-2029) & (Kg)
Table 101. North America Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2018-2023) & (Kg)
Table 104. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2024-2029) & (Kg)
Table 105. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2018-2023) & (Kg)
Table 106. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2024-2029) & (Kg)
Table 107. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Country (2018-2023) & (Kg)
Table 108. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Country (2024-2029) & (Kg)
Table 109. Europe Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2018-2023) & (Kg)
Table 112. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2024-2029) & (Kg)
Table 113. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2018-2023) & (Kg)
Table 114. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2024-2029) & (Kg)
Table 115. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Region (2018-2023) & (Kg)
Table 116. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Region (2024-2029) & (Kg)
Table 117. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2018-2023) & (Kg)
Table 120. South America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2024-2029) & (Kg)
Table 121. South America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2018-2023) & (Kg)
Table 122. South America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2024-2029) & (Kg)
Table 123. South America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Country (2018-2023) & (Kg)
Table 124. South America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Country (2024-2029) & (Kg)
Table 125. South America Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2018-2023) & (Kg)
Table 128. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Type (2024-2029) & (Kg)
Table 129. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2018-2023) & (Kg)
Table 130. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Application (2024-2029) & (Kg)
Table 131. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Region (2018-2023) & (Kg)
Table 132. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity by Region (2024-2029) & (Kg)
Table 133. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 135. Adeno-Associated Virus Vectors in Gene Therapy Raw Material
Table 136. Key Manufacturers of Adeno-Associated Virus Vectors in Gene Therapy Raw Materials
Table 137. Adeno-Associated Virus Vectors in Gene Therapy Typical Distributors
Table 138. Adeno-Associated Virus Vectors in Gene Therapy Typical Customers
LIST OF FIGURES
Figure 1. Adeno-Associated Virus Vectors in Gene Therapy Picture
Figure 2. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value Market Share by Type in 2022
Figure 4. Serotype 2 (AVV 2) Examples
Figure 5. Synthetic Serotypes Examples
Figure 6. Others Examples
Figure 7. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value Market Share by Application in 2022
Figure 9. Alzheimer's Disease Examples
Figure 10. Cystic Dibrosis Examples
Figure 11. Hemophilia B Examples
Figure 12. Parkinson's Disease Examples
Figure 13. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (2018-2029) & (Kg)
Figure 16. Global Adeno-Associated Virus Vectors in Gene Therapy Average Price (2018-2029) & (US$/Kg)
Figure 17. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Adeno-Associated Virus Vectors in Gene Therapy by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Adeno-Associated Virus Vectors in Gene Therapy Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Adeno-Associated Virus Vectors in Gene Therapy Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Adeno-Associated Virus Vectors in Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Adeno-Associated Virus Vectors in Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Adeno-Associated Virus Vectors in Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Type (2018-2029) & (US$/Kg)
Figure 32. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Application (2018-2029) & (US$/Kg)
Figure 35. North America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Adeno-Associated Virus Vectors in Gene Therapy Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Adeno-Associated Virus Vectors in Gene Therapy Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Consumption Value Market Share by Region (2018-2029)
Figure 55. China Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Adeno-Associated Virus Vectors in Gene Therapy Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Adeno-Associated Virus Vectors in Gene Therapy Market Drivers
Figure 76. Adeno-Associated Virus Vectors in Gene Therapy Market Restraints
Figure 77. Adeno-Associated Virus Vectors in Gene Therapy Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Adeno-Associated Virus Vectors in Gene Therapy in 2022
Figure 80. Manufacturing Process Analysis of Adeno-Associated Virus Vectors in Gene Therapy
Figure 81. Adeno-Associated Virus Vectors in Gene Therapy Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Figure 1. Adeno-Associated Virus Vectors in Gene Therapy Picture
Figure 2. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value Market Share by Type in 2022
Figure 4. Serotype 2 (AVV 2) Examples
Figure 5. Synthetic Serotypes Examples
Figure 6. Others Examples
Figure 7. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value Market Share by Application in 2022
Figure 9. Alzheimer's Disease Examples
Figure 10. Cystic Dibrosis Examples
Figure 11. Hemophilia B Examples
Figure 12. Parkinson's Disease Examples
Figure 13. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity (2018-2029) & (Kg)
Figure 16. Global Adeno-Associated Virus Vectors in Gene Therapy Average Price (2018-2029) & (US$/Kg)
Figure 17. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Adeno-Associated Virus Vectors in Gene Therapy by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Adeno-Associated Virus Vectors in Gene Therapy Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Adeno-Associated Virus Vectors in Gene Therapy Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Adeno-Associated Virus Vectors in Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Adeno-Associated Virus Vectors in Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Adeno-Associated Virus Vectors in Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Type (2018-2029) & (US$/Kg)
Figure 32. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Adeno-Associated Virus Vectors in Gene Therapy Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Adeno-Associated Virus Vectors in Gene Therapy Average Price by Application (2018-2029) & (US$/Kg)
Figure 35. North America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Adeno-Associated Virus Vectors in Gene Therapy Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Adeno-Associated Virus Vectors in Gene Therapy Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Adeno-Associated Virus Vectors in Gene Therapy Consumption Value Market Share by Region (2018-2029)
Figure 55. China Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Adeno-Associated Virus Vectors in Gene Therapy Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Adeno-Associated Virus Vectors in Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Adeno-Associated Virus Vectors in Gene Therapy Market Drivers
Figure 76. Adeno-Associated Virus Vectors in Gene Therapy Market Restraints
Figure 77. Adeno-Associated Virus Vectors in Gene Therapy Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Adeno-Associated Virus Vectors in Gene Therapy in 2022
Figure 80. Manufacturing Process Analysis of Adeno-Associated Virus Vectors in Gene Therapy
Figure 81. Adeno-Associated Virus Vectors in Gene Therapy Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
